Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-&#954;B activation.

Xu, Zihang; Hou, Yifei; Zou, Chunpu; Liang, Haibin; Mu, Jiasheng; Jiao, Xiaoning; Zhu, Yangzhuangzhuang; Su, Lin; Liu, Mingxi; Chen, Xiao; Qian, Chunmei; Zhu, Xiandan; Gong, Wei; Dong, Qian; Zhang, Fei

Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-κB activation.

Xu, Zihang; Hou, Yifei; Zou, Chunpu; Liang, Haibin; Mu, Jiasheng; Jiao, Xiaoning; Zhu, Yangzhuangzhuang; Su, Lin; Liu, Mingxi; Chen, Xiao; Qian, Chunmei; Zhu, Xiandan; Gong, Wei; Dong, Qian; Zhang, Fei.

Afiliação

Xu Z; Shanghai Key Laboratory of Health Identification and Assessment, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Hou Y; Shanghai Key Laboratory of Health Identification and Assessment, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Zou C; Shanghai Key Laboratory of Health Identification and Assessment, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Liang H; Department of General Surgery, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Mu J; Department of General Surgery, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Jiao X; Shanghai Key Laboratory of Health Identification and Assessment, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Zhu Y; Shanghai Key Laboratory of Health Identification and Assessment, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Su L; Shanghai Key Laboratory of Health Identification and Assessment, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Liu M; Shanghai Key Laboratory of Health Identification and Assessment, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Chen X; Shanghai Key Laboratory of Health Identification and Assessment, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Qian C; Experimental Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Zhu X; Experimental Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Gong W; Department of General Surgery, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Dong Q; Department of General Surgery, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Zhang F; Department of General Surgery, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.

Int J Biol Sci ; 18(7): 2759-2774, 2022.

Article em En | MEDLINE | ID: mdl-35541911

Assuntos

NF-kappa B; Neoplasias Pancreáticas; Antraquinonas; Apoptose; Linhagem Celular Tumoral; Humanos; NF-kappa B/metabolismo; Neoplasias Pancreáticas/metabolismo; Fator de Necrose Tumoral alfa/farmacologia; Ensaios Antitumorais Modelo de Xenoenxerto; Neoplasias Pancreáticas

Palavras-chave

Alizarin; Gemcitabine; NF-κB signal; Nature compound; Pancreatic cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / NF-kappa B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Int J Biol Sci Assunto da revista: BIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google